Fredun Pharmaceuticals Ltd vs Kobo Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Fredun Pharmaceuticals Ltd is ₹ 2299 as of 04 May 10:58 . The P/E Ratio of Fredun Pharmaceuticals Ltd changed from 91.8 on March 2021 to 21.6 on March 2024 . This represents a CAGR of -30.35% over 4 yearsThe P/E Ratio of Kobo Biotech Ltd changed from 0 on March 2021 to 0 on March 2024 . This represents a CAGR of 0.0% over 4 years The Market Cap of Fredun Pharmaceuticals Ltd changed from ₹ 184.94 crore on March 2021 to ₹ 337.07 crore on March 2024 . This represents a CAGR of 16.19% over 4 yearsThe Market Cap of Kobo Biotech Ltd changed from ₹ 17.63 crore on March 2021 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 4 years The revenue of Fredun Pharmaceuticals Ltd for the Dec '25 is ₹ 160.92 crore as compare to the Sep '25 revenue of ₹ 145.29 crore. This represent the growth of 10.76% The revenue of Kobo Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Fredun Pharmaceuticals Ltd for the Dec '25 is ₹ 26.34 crore as compare to the Sep '25 ebitda of ₹ 22.33 crore. This represent the growth of 17.96% The ebitda of Kobo Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Fredun Pharmaceuticals Ltd changed from ₹ 13.74 crore to ₹ 10.48 crore over 5 quarters. This represents a CAGR of -19.48% The net profit of Kobo Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Fredun Pharmaceuticals Ltd changed from 13.9 % on March 2021 to 2.11 % on March 2024 . This represents a CAGR of -37.58% over 4 yearsThe Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2024 . This represents a CAGR of 0.0% over 4 years .

About Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.'94.
The Company was promoted by Nariman Medhora and Daulat N Medhora.
The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations.
Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy.
The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products.

About Kobo Biotech Ltd

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

FAQs for the comparison of Fredun Pharmaceuticals Ltd and Kobo Biotech Ltd

Which company has a larger market capitalization, Fredun Pharmaceuticals Ltd or Kobo Biotech Ltd?

Market cap of Fredun Pharmaceuticals Ltd is 1,229 Cr while Market cap of Kobo Biotech Ltd is 6 Cr

What are the key factors driving the stock performance of Fredun Pharmaceuticals Ltd and Kobo Biotech Ltd?

The stock performance of Fredun Pharmaceuticals Ltd and Kobo Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fredun Pharmaceuticals Ltd and Kobo Biotech Ltd?

As of May 4, 2026, the Fredun Pharmaceuticals Ltd stock price is INR ₹2230.9. On the other hand, Kobo Biotech Ltd stock price is INR ₹2.85.

How do dividend payouts of Fredun Pharmaceuticals Ltd and Kobo Biotech Ltd compare?

To compare the dividend payouts of Fredun Pharmaceuticals Ltd and Kobo Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.